SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Schumer working toward compromise on banking reform and expungements

    By

    HOPE FOR REFORM

    Schumer is pushing to progress the SAFE and HOPE acts.

    Senate Majority Leader Chuck Schumer (D-NY) is working on “interim, bipartisan cannabis reform” initiatives with Rep. Dave Joyce (R-OH) while working toward full federal legalization, according to Marijuana Moment.

    The interim proposals include SAFE Banking, which would protect financial institutions from federal consequences for working with state legal cannabis businesses, and the HOPE Act, which would expunge cannabis convictions. 

    “The conversation between Leader Schumer and Congressman Joyce was part of an ongoing, broader discussion between both parties and chambers to determine what reform can pass this Congress,” said a Joyce senior staffer. “It is evidence of the sincere efforts by both the leader and the congressman to find common ground for substantial, bipartisan progress on this issue. The congressman remains hopeful that an agreement can be made and progress can be achieved.”


    Enjoy Cannabis Daily each morning at 7 a.m.

    LOW SALES

    Colorado cannabis sales haven’t recovered—not even on 4/20

    Despite hopes that 4/20 would help Colorado cannabis sales bounce back, that was not the case, per Westword.

    According to the Department of Revenue:

    • April 2022 sales in the state reached more than USD $153 million 
    • April 2021 sales were 26% higher, at USD $206.3 million
    • March 2022 sales reached USD $162.5 million

    2021 saw record-breaking sales for retailers in the state. But ever since, monthly sales have dropped.


    LESS TESTS

    Why Utah stopped testing medical cannabis for some contaminants

    As of April 2021, the Utah Department of Agriculture and Food stopped requiring medical cannabis cultivators to test for salmonella, E.coli and some molds, reports the Salt Lake Tribune.

    The department is citing supply chain issues and a lack of access to equipment such as pipette tips to collect samples.

    General tests for contaminants such as the total yeast and mold have continued, but unfortunately for medical cannabis consumers, “There is no way the state can say with certainty that products on dispensary shelves are free of pathogens like E.coli, salmonella or mold.”


    10 June 2026 · Berlin Sales end May 29

    European Cannabis
    Insights Summit

    From €216

    200+ industry leaders. Exclusive German market data. A half-day briefing for B2B operators in Europe's most important emerging cannabis market.

    Mike Hoban

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free